Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix-Reference-Cited by-同舟云学术

Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix

Published:2013-06 Issue:3 Volume:129 Page:513-516
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Costales Anthony B.,Milbourne Andrea M.,Rhodes Helen E.,Munsell Mark F.,Wallbillich John J.,Brown Jubilee,Frumovitz Michael,Ramondetta Lois M.,Schmeler Kathleen M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference30 articles.

1. Primary adenocarcinoma of the cervix;Hepler;Am J Obstet Gynecol,1952

2. Conservative management of adenocarcinoma in situ of the cervix;Shin;Gynecol Oncol,2000

3. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix;Madeleine;Cancer Epidemiol Biomarkers Prev,2001

4. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix;Denehy;Obstet Gynecol,1997

5. Further study of the management of cervical adenocarcinoma in situ;Kennedy;Gynecol Oncol,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follow-up of women with cervical adenocarcinoma in situ treated by conization: A single centre clinical experience;Gynecologic Oncology;2024-08

2. Adenocarcinoma In Situ of the Uterine Cervix (AIS) Treated by Loop Electrosurgical Excision Procedure Strategy: An Observational Study;Journal of Lower Genital Tract Disease;2024-01-16

3. Predictors of treatment failure for adenocarcinoma in situ of the uterine cervix: Up to 14 years of recorded follow‑up;Oncology Letters;2022-08-25

4. Atypical glandular cells (AGC): Cytology of glandular lesions of the uterine cervix;Cytojournal;2022-04-30

5. Histological results after large loop excision of the transformation zone procedure: analysis and frequency distribution;Medical Studies;2022